| Gene symbol | BIRC5 | Synonyms | API4, EPR-1 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | baculoviral IAP repeat containing 5 | ||||
| Gene symbol | TERT | Synonyms | CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT | Type of gene | protein-coding |
| Chromosome | 5 | Map location | 5p15.33 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | telomerase reverse transcriptase | ||||
| GTO ID | GTC1903 |
| Trial ID | NCT03548571 |
| Disease | Glioblastoma |
| Altered gene | BIRC5|TERT |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Co-treatment | temozolomide |
| Phase | Phase2|Phase3 |
| Recruitment status | Active, Not Recruiting |
| Title | Open Label Randomized Phase II/III Trial of Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy (DEN-STEM) |
| Year | 2018 |
| Country | Norway |
| Company sponsor | Oslo University Hospital |
| Other ID(s) | DEN-STEM |
| Vector information | |||
|
|||
| Cohort1: IMP | |||||||
|
|||||||
| Cohort2: Standard therapy | |||||||
|
|||||||